Article Details
Retrieved on: 2025-02-17 12:57:15
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights Becton, Dickinson and Company's underperformance compared to the S&P 500 and iShares U.S. Medical Devices ETF, despite earnings surprises and strong guidance. As a key player in MedTech, analysts view BDX favorably with a "Strong Buy" consensus and potential upside.
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here